Brian Rady, Ph.D.
Affiliations: | 2013 | Bioengineering | University of Illinois at Chicago, Chicago, IL, United States |
Area:
Biomedical Engineering, Cell Biology, PathologyGoogle:
"Brian Rady"Parents
Sign in to add mentor| Jose Oberholzer | grad student | 2013 | University of Illinois, Chicago | |
| (Transcription factors E2F have a role in proliferation of beta-cells and development of type-2 diabetes.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rady B, Liu J, Huang H, et al. (2022) A FFAR1 full agonist restores islet function in models of impaired glucose-stimulated insulin secretion and diabetic non-human primates. Frontiers in Endocrinology. 13: 1061688 |
| Marselli L, Piron A, Suleiman M, et al. (2020) Persistent or Transient Human β Cell Dysfunction Induced by Metabolic Stress: Specific Signatures and Shared Gene Expression with Type 2 Diabetes. Cell Reports. 33: 108466 |
| LIU J, LEE SP, MARTIN T, et al. (2018) FFAR1 Agonism Restores Insulin Secretion in Rodents, Human Islets, and Diabetic Monkeys Diabetes. 67: 609-P |
| Wang Y, Qi M, McGarrigle JJ, et al. (2013) Use of glucagon-like peptide-1 agonists to improve islet graft performance. Current Diabetes Reports. 13: 723-32 |
| Rady B, Chen Y, Vaca P, et al. (2013) Overexpression of E2F3 promotes proliferation of functional human β cells without induction of apoptosis. Cell Cycle (Georgetown, Tex.). 12: 2691-702 |
| Wang Y, Mendoza-Elias JE, McGarrigle JJ, et al. (2013) Application of microfluidic technology for studying islet physiology and pathophysiology Micro and Nanosystems. 5: 216-223 |